If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Simon Spazzapan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Tamoxifen Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
exemestane Medicine & Life Sciences
letrozole Medicine & Life Sciences
Anthracyclines Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

Adjuvant letrozole and tamoxifen alone or sequentially for postmenopausal women with hormone receptor-positive breast cancer: Long-term follow-up of the BiG 1-98 trial

BIG 1-98 Collaborative Group and the International Breast Cancer Study Group, Jan 10 2019, In : Journal of Clinical Oncology. 37, 2, p. 105-114 10 p.

Research output: Contribution to journalArticle

letrozole
Tamoxifen
Hormones
Breast Neoplasms
Disease-Free Survival

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

Ruhstaller, T., Giobbie-Hurder, A., Colleoni, M., Jensen, M-B., Ejlertsen, B., de Azambuja, E., Neven, P., Láng, I., Jakobsen, E. H., Gladieff, L., Bonnefoi, H., Harvey, V. J., Spazzapan, S., Tondini, C., Del Mastro, L., Veyret, C., Simoncini, E., Gianni, L., Rochlitz, C., Kralidis, E. & 10 others, Zaman, K., Jassem, J., Piccart-Gebhart, M., Di Leo, A., Gelber, R. D., Coates, A. S., Goldhirsch, A., Thürlimann, B., Regan, M. M. & Group, M. O. T. BIG. . C. G. A. T. I. B. C. S., Jan 10 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 2, p. 105-114 10 p.

Research output: Contribution to journalArticle

letrozole
Tamoxifen
Breast
Hormones
Breast Neoplasms

Post-neoadjuvant strategies in breast cancer: From risk assessment to treatment escalation

Pelizzari, G., Gerratana, L., Basile, D., Fanotto, V., Bartoletti, M., Liguori, A., Fontanella, C., Spazzapan, S. & Puglisi, F., Jan 1 2019, In : Cancer Treatment Reviews. 72, p. 7-14 8 p.

Research output: Contribution to journalReview article

Neoadjuvant Therapy
Breast Neoplasms
Drug Therapy
Cyclin-Dependent Kinase 6
Biomarkers

Ten daily fractions for partial breast irradiation. Long-term results of a prospective phase II trial

Vinante, L., Avanzo, M., Furlan, C., Fiorica, F., Perin, T., Militello, L., Spazzapan, S., Berretta, M., Jena, R., Stancanello, J., Piccoli, E., Mileto, M., Micheli, E., Roncadin, M., Massarut, S. & Trovò, M., Mar 1 2019, In : Breast Journal. 25, 2, p. 243-249 7 p.

Research output: Contribution to journalArticle

Breast
Breast Neoplasms
Conformal Radiotherapy
Disease-Free Survival
Fibrosis

Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE

Leo, S., Arnoldi, E., Repetto, L., Coccorullo, Z., Cinieri, S., Fedele, M., Cazzaniga, M., Lorusso, V., Latorre, A., Campanella, G., Ciccarese, M., Accettura, C., Pisconti, S., Rinaldi, A., Brunetti, C., Raffaele, M., Coltelli, L., Spazzapan, S., Fratino, L., Petrucelli, L. & 1 others, Biganzoli, L., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

eribulin
Geriatrics
Observational Studies
Geriatric Assessment
Breast Neoplasms